Creo Medical Group (FRA:1RC) FCF Margin %: -921.11% (As of Dec. 2025)


FRA:1RC Creo Medical Group PLC FRA:1RC
53 GF Score
Price €0.15
GF Value €0.18
! 6 Warning Signs
View Full Analysis

What is Creo Medical Group FCF Margin %?

Creo Medical Group FRA:1RC 53 FCF Margin % is -921.11% as of Dec. 2025. GuruFocus rates FRA:1RC with a GF Score™ of 53/100 and a GF Value™ of €0.18. The stock has 6 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Creo Medical Group ranks worse than 90.67% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Creo Medical Group's Free Cash Flow for the six months ended in Dec. 2025 was €-40.01 Mil. Creo Medical Group's Revenue for the six months ended in Dec. 2025 was €4.34 Mil. Therefore, Creo Medical Group's FCF Margin % for the quarter that ended in Dec. 2025 was -921.11%.

As of today, Creo Medical Group's current FCF Yield % is -30.30%.

The historical rank and industry rank for Creo Medical Group's FCF Margin % or its related term are showing as below:

FRA:1RC' s FCF Margin % Range Over the Past 10 Years
Min: -99769.23   Med: -333.33   Max: -103.68
Current: -322.66

During the past 11 years, the highest FCF Margin % of Creo Medical Group was -103.68%. The lowest was -99769.23%. And the median was -333.33%.

FRA:1RC's FCF Margin % is ranked worse than
90.67% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: -0.03 vs FRA:1RC: -322.66

Creo Medical Group FCF Margin % Related Terms

Creo Medical Group FCF Margin % Historical Data

* Premium members only.

The historical data trend for Creo Medical Group's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Creo Medical Group FCF Margin % Chart

Creo Medical Group Annual Data
Trend Feb15 Feb16 Jun17 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -127.71 -103.67 -579.99 -565.04 -333.36

Creo Medical Group Semi-Annual Data
Feb15 Feb16 Dec16 Jun17 Dec17 Jun18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 64.10 -893.76 -345.79 681.84 -921.11

FRA:1RC vs ABT, SYK, MDT: FCF Margin % Comparison

For the Medical Devices subindustry, Creo Medical Group's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Creo Medical Group FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Creo Medical Group's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Creo Medical Group's FCF Margin % falls into.


FRA:1RC
53GF Score
Creo Medical Group PLC FRA:1RC
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Creo Medical Group FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Creo Medical Group's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-22.865/6.859
=-333.36 %

Creo Medical Group's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-40.013/4.344
=-921.11 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -921.11% mean?
Creo Medical Group (FRA:1RC) has a FCF Margin % of -921.11% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Creo Medical Group and its competitors. According to the industry distribution chart, Creo Medical Group ranks #739 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 90.7%.
Is Creo Medical Group's FCF Margin % too high?
Creo Medical Group's current FCF Margin % is -921.11%. Based on the distribution chart, Creo Medical Group ranks #739 out of 815 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Creo Medical Group has a GF Score™ of 53/100, reflecting its overall financial health beyond just this single metric.
How does Creo Medical Group's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Creo Medical Group ranks #739 out of 815 companies for FCF Margin %. This places Creo Medical Group in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Creo Medical Group and its competitors. Creo Medical Group's current FCF Margin % is -921.11%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Creo Medical Group stock overvalued right now?
Creo Medical Group (FRA:1RC) has a current FCF Margin % of -921.11%. The stock's GF Value™ is €0.18, compared to a current price of €0.15 — trading 18.9% below its estimated fair value. The current FCF Margin % is -921.11%. Creo Medical Group's overall GF Score™ is 53/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Creo Medical Group (FRA:1RC), the current FCF Margin % is -921.11% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Creo Medical Group (FRA:1RC) Overvalued in 2026?

Based on GuruFocus' analysis, Creo Medical Group stock appears to be undervalued. The current stock price of €0.15 is trading 18.9% below its estimated GF Value™ of €0.18.

Key valuation signals for FRA:1RC:

  • FCF Margin %: -921.11%
  • GF Value™: €0.18 vs. price of €0.15 (18.9% below fair value)
  • GF Score™: 53/100 with 6 warning signs

No single metric tells the full story. See the FRA:1RC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Creo Medical Group Business Description

Other Exchanges CREO:UK
Address Beaufort Park Way, Unit 2, Creo House, Beaufort Park, Chepstow, GBR, NP16 5UH
Creo Medical Group PLC is a medical device company engaged in providing services in the field of surgical endoscopy. The company has developed a platform called Croma which is an electrosurgical platform to deliver microwave and bipolar radiofrequency through a single accessory port. The reportable segment of the company is the research and development of electrosurgical medical devices relating to the field of surgical endoscopy. Geographically, the company generates a majority of its revenue from United Kingdom and the rest from Europe and the rest of the world.
53GF Score

Get the complete analysis for FRA:1RC

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.15
Price
€0.18
GF Value